Hans Klingemann

Hans Klingemann

Chief Tech/Sci/R&D Officer bij IMMUNITYBIO, INC.

74 jaar
Health Technology
Consumer Services
Health Services

Profiel

Hans Georg Klingemann was the founder of NantKwest, Inc. (founded in 2002) where he held the title of Director, Chief Medical & Scientific Officer from 2012 to 2015.
He is currently the Chief Science Officer–Cellular at ImmunityBio, Inc. Dr. Klingemann's former positions include being an Independent Non-Executive Director at Osiris Therapeutics, Inc. from 2012 to 2016, Director-Bone Marrow Transplant at Rush University Medical Center, Director at Bone Marrow & Cancer Foundation, Inc., and Director-Stem Cell Transplant at Tufts Medical Center, Inc.Dr. Klingemann obtained a doctorate degree from Philipps University of Marburg and the University of Würzburg Medical School.

Actieve functies van Hans Klingemann

BedrijvenFunctieBegin
IMMUNITYBIO, INC. Chief Tech/Sci/R&D Officer -
Alle actieve functies van Hans Klingemann

Eerdere bekende functies van Hans Klingemann

BedrijvenFunctieEinde
OSIRIS THERAPEUTICS, INC. Director/Board Member 11-06-2016
Corporate Officer/Principal -
Corporate Officer/Principal -
Director/Board Member -
IMMUNITYBIO, INC. Founder -
Ervaring van Hans Klingemann in detail bekijken

Opleiding van Hans Klingemann

Philipps University of Marburg Doctorate Degree
University of Würzburg Medical School Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Hans Klingemann in detail bekijken

Connecties

35

Eerstegraads connecties

8

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven1
IMMUNITYBIO, INC.

Health Technology

Bedrijven in privébezit5

Health Technology

Health Technology

Health Services

Commercial Services

Health Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. Hans Klingemann